Contact
Please use this form to send email to PR contact of this press release:
Human medicines European public assessment report (EPAR): Epclusa, sofosbuvir,velpatasvir, Hepatitis C, Chronic, Date of authorisation: 06/07/2016, Revision: 20, Status: Authorised
TO: